116 results
8-K
EX-99.1
IMUX
Immunic Inc
8 May 24
Immunic, Inc. Reports First Quarter 2024 Financial Results and Provides Corporate Update
6:45am
expenses
Other current liabilities
Total current liabilities
Long-term liabilities
Operating lease liabilities
Total long-term liabilities
Total
424B3
IMUX
Immunic Inc
30 Apr 24
Prospectus supplement
5:16pm
return in the short term or long term. Investing in our common stock is speculative and involves a high degree of risk and should be undertaken only
8-K
EX-99.1
3cx g2qf9msgih9mj
22 Feb 24
Immunic, Inc. Reports Year End 2023 Financial Results and Provides Corporate Update
6:35am
PRE 14A
jcm8x2 gug
24 Jan 24
Preliminary proxy
5:05pm
8-K
EX-10.2
v1qr7eq
21 Dec 23
Departure of Directors or Certain Officers
8:30am
8-K
EX-10.4
ufsum9edz btk8879yb
21 Dec 23
Departure of Directors or Certain Officers
8:30am
8-K
EX-10.1
j7ghy1nyzgu9fv banvx
21 Dec 23
Departure of Directors or Certain Officers
8:30am
8-K
EX-10.3
rj9fj758qdfrwkvfj2lh
21 Dec 23
Departure of Directors or Certain Officers
8:30am
8-K
EX-99.1
qc2mx y4zr794y9
14 Nov 23
Immunic, Inc. Reports Third Quarter 2023 Financial Results and Provides Corporate Update
6:38am
8-K
EX-99.1
xxpveth4r72c0n
3 Aug 23
Immunic, Inc. Reports Second Quarter 2023 Financial Results and Provides Corporate Update
6:44am
8-K
EX-99.1
19hv26e7 mpm6sb0
11 May 23
Immunic, Inc. Reports First Quarter 2023 Financial Results and Provides Corporate Update
8:51am